Prof. Dr. Ugur Sahin

Prof. Ugur Sahin, M.D. is an entrepreneurial researcher and inventor who has made essential contributions to more than 60 independent patents in various life sciences and biotechnology fields, including pioneering innovations that provide the basis for the foundation of BioNTech SE.

Ugur is the co-founder and CEO of BioNTech SE. His key focus is translating scientific ideas into innovations that help individual patients, an interest that was originally prompted by his experiences as a trained physician. Ugur has received prestigious awards from the German Hemato-Oncology Association, the German Association for Immunology, the German Ministry of Education and Research, and the American Society of Clinical Oncology. He is a co-founder of Ganymed Pharmaceuticals, a co-founder and chair of the translational research institute TRON, and a co-founder of the CI3- Rhein-Main Cluster for Individualized Immune Intervention.

Ugur Sahin